Rv1630 - c.18C>A
Drug resistance types
21 Sensitive
0 RR-TB
3 HR-TB
6 MDR-TB
2 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.1.2.1 | 31 |
| lineage4.1.2.1;lineage4.5 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 32 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR29049024 | MDR-TB | lineage4.1.2.1 | None | SRR22250054 | Sensitive | lineage4.1.2.1 | None | SRR29016852 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR29096951 | HR-TB | lineage4.1.2.1 | None | ERR13265366 | Sensitive | lineage4.1.2.1 | None | SRR28044528 | MDR-TB | lineage4.1.2.1 | None | SRR29772626 | MDR-TB | lineage4.1.2.1 | None | ERR4831055 | Sensitive | lineage4.1.2.1 | np | SRR27450174 | Sensitive | lineage4.1.2.1 | None | ERR1213885 | HR-TB | lineage4.1.2.1 | np | ERR13265823 | Sensitive | lineage4.1.2.1 | None | SRR27450602 | Sensitive | lineage4.1.2.1 | None | SRR22250082 | Sensitive | lineage4.1.2.1 | None | ERR13265434 | Sensitive | lineage4.1.2.1 | None | ERR4831052 | Sensitive | lineage4.1.2.1 | np | SRR30182447 | Sensitive | lineage4.1.2.1 | None | SRR28044419 | Sensitive | lineage4.1.2.1 | None | SRR21662007 | Sensitive | lineage4.1.2.1 | None | ERR13266774 | Pre-XDR-TB | lineage4.1.2.1 | None | SRR22251689 | Sensitive | lineage4.1.2.1 | None | SRR27450119 | Sensitive | lineage4.1.2.1 | None | SRR22251491 | Sensitive | lineage4.1.2.1 | None | SRR22249944 | Sensitive | lineage4.1.2.1;lineage4.5 | None | ERR3132125 | HR-TB | lineage4.1.2.1 | None | SRR29096113 | MDR-TB | lineage4.1.2.1 | None | SRR30182815 | Sensitive | lineage4.1.2.1 | None | ERR8773933 | MDR-TB | lineage4.1.2.1 | None | ERR8773935 | MDR-TB | lineage4.1.2.1 | None | SRR22251257 | Sensitive | lineage4.1.2.1 | None | ERR13266267 | Sensitive | lineage4.1.2.1 | None | ERR13265072 | Sensitive | lineage4.1.2.1 | None | SRR22251422 | Sensitive | lineage4.1.2.1 | None |
|---|
